National Hemophilia Program Coordinating Center

Background
The U.S. Department of Health and Human Services (HHS) is accepting applications for two separate projects to be awarded in fiscal year (FY) 2022 - HRSA-22-068, the Regional Hemophilia Network (RHN) (Project 1) and HRSA-22-079, the National Hemophilia Program Coordinating Center (NHPCC) (Project 2). The purpose of these programs is to improve access to coordinated, evidence-based care for patients with hemophilia and related bleeding or clotting disorders and their families. The Maternal and Child Health Bureau (MCHB) administers programs with focus areas in maternal and women’s health, adolescent and young adult health, perinatal and infant health, child health, and children with special health care needs.

Grant Details
The goal of HRSA-22-079 is for one recipient to provide subject matter expertise, technical assistance and programmatic support to the RHNs through a national coordinating center. HRSA-22-079 will enhance coordination across the regions, increase the programs’ ability to respond to emerging needs in the field, and strengthen the capacity of the RHN and HTC comprehensive care teams through targeted TA and by tracking national, regional, and patient-level data to assess patient outcomes. The NHPCC also provides an ongoing forum for national education, communication, and collaboration that assists in increasing the evidence base on care for patients seen in HTCs.

Eligibility Requirements
Any domestic public or private entity, including an Indian tribe or tribal organization is eligible to apply. Domestic faith-based and community-based organizations are also eligible to apply.

Period of Performance
The period of performance for both projects is from June 1, 2022, through May 31, 2027 (5 years). Funding beyond the first year is subject to the availability of appropriated funds for subsequent fiscal years.

Grant Value
HRSA-22-068: Regional Hemophilia Network Program has an estimated annual funding of $500,000 per recipient for up to eight recipients.
HRSA-22-079: National Hemophilia Program Coordinating Center has an estimated annual funding of $740,000 for one recipient.